Bruker constantly invests in the product portfolio development and improvement to maintain the global market leadership in MALDI-TOF technology. It is of great importance to Bruker to design robust, compact, high performance platforms intended for extensive and routine usage in the clinical microbiology laboratory.
Continuous hardware development has led to the 4th generation of Bruker’s benchtop MALDI Biotyper® systems, with a new ‘sirius’ member of the product family.